American Journal of Biological Defense ®

 
 
 
 
  
Due to the current Covid-19 pandemic we have taken the unprecedented step of communicating relevant software and manual for contagion risk management free to the public. As a private foundation our goal  is to reduce global economic burden for infectious diseases and cancers. To this end, we develop and market US FDA approved vitamins like Olisferrol®(Braunmycin) that enrich blood-plasma anti-infection content and publish online epidemic attack rate and risk surveillance software along with independent research from authors utilizing BiologicalAgents® [Indx]™ software outputs. To assist support our effort through Go Fund Me or via our Blood-Plasma drive.
Bookmark and Share
Follow Us On: